CURE® Announces Call for Nominations for GBM Heroes to Be Recognized at Night of Celebration During 21st Annual Scientific Meeting of Society for Neuro-Oncology

Plainsboro, N.J. (PRWEB) August 24, 2016

CURE� magazine is calling for nominations for its Glioblastoma (GBM) Heroes who will be recognized at a gala celebration in Scottsdale, Ariz., on Nov. 18, during the 21st Annual Scientific Meeting of the Society for Neuro-Oncology. Fran Drescher--actress, author, health advocate, cancer survivor and founder of the Cancer Schmancer Movement--will be the guest speaker at the second annual event.

CURE magazine's GBM Heroes Recognition program, sponsored by global oncology company Novocure, is accepting nominations from patients, healthcare professionals and advocates for GBM Heroes who have made a difference in the lives of people with GBM. Four winners and the individuals who nominated them will join CURE in Scottsdale to be honored at the 2nd Annual GBM Heroes Recognition.

"We are proud to recognize and celebrate the individuals who have excelled in their efforts to raise awareness and education around glioblastoma. We are also pleased to welcome award-winning actress, author and cancer advocate, Fran Drescher, as the guest speaker and look forward to her insight as a cancer survivor and strong advocate for cancer prevention and early detection," said Mike Hennessy Jr., president of CURE Media Group.

Glioblastoma multiforme is the most aggressive and most common form of primary brain tumor in the U.S. and affects approximately 10,000 people every year. The median overall survival time from initial diagnosis is 15 months with optimal treatment; median survival from the time of tumor recurrence is 3 to 5 months without additional effective treatments.

Fran Drescher is a 16-year uterine cancer survivor. She is well recognized for her portrayal as "Miss Fine" in the hit series The Nanny, for which she received two Emmy and two Golden Globe nominations. She is the author of New York Times best-sellers Cancer Schmancer and Enter Whining, as well as a children's book entitled Being Wendy. As a cancer advocate and founder of the Cancer Schmancer Movement, she focuses on a three-pronged approach to fighting the disease: early detection, prevention and advocacy.

GBM Hero nomination forms are available at http://www.curetoday.com/events/gbm and will be accepted through Sept. 15. Completed forms may be e-mailed to GBMheroes(at)curetoday(dot)com or mailed to CURE, Attention: GBM Heroes Award, Office Center at Princeton Meadows, 666 Plainsboro Rd., Building 300, Plainsboro, N.J. 08536. Reservations to attend the 2016 GBM Heroes award ceremony, which will be held at the Fairmont Scottsdale Princess in Scottsdale, may be made by visiting the website above and clicking on RSVP.

About CURE magazine
CURE magazine is CURE Media Group's flagship product and an indispensable guide to every stage of the cancer continuum. With nearly 1 million readers who include cancer patients, cancer centers and advocacy groups, CURE is the largest consumer publication in the U.S. that focuses solely on cancer. CURE Media Group was acquired in 2014 by Michael J. Hennessy Associates, Inc. (MJH), and joined CURE with MJH's acclaimed OncLive® (http://www.onclive.com) platform of resources for the practicing oncologist.

About Novocure
Novocure is a global oncology company pioneering a novel therapy for solid tumors called Tumor Treating Fields, or TTFields. Headquartered in Jersey Isle, Novocure's US operations are based in Portsmouth, N.H., and New York, N.Y. The company also has offices in Switzerland, Germany and Japan and a research Center in Haifa, Israel.

About Cancer Schmancer
Cancer Schmancer, a tax-exempt organization based in Malibu, Calif., was founded by Fran Drescher. The organization's mission is to save lives by shifting the nation's focus from just searching for a cure for cancer to prevention and early detection. The Cancer Schmancer Movement is a three-pronged organization dedicated to early cancer detection, prevention and policy change.

For more information, contact:
For CURE magazine: Becky Taylor, 609-240-6886 or becky(at)btaylorpa(dot)com
For Cancer Schmancer: info(at)cancerschmancer(dot)org

Read the full story at http://www.prweb.com/releases/CURE/GBMHeroes2016/prweb13615948.htm

You May Also Be Interested In

• BioMedNewsBreaks — HeartBeam Inc. (NASDAQ: BEAT) Schedules Conference Call to Discuss Q1 2024 Results
• Jeff Martin Auctioneers to Manage Sale of Sabine Mining Company Assets for North American Coal
• PPX Continues To Deliver Solid Exploration Results At Callanquitas With Up To 18.93 Au g/t